carbamylhydrazine has been researched along with Leukemia, Myeloid, Acute in 1 studies
carbamylhydrazine: RN given refers to parent cpd
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Q | 1 |
| Dai, B | 1 |
| Li, Z | 1 |
| Xu, L | 1 |
| Yang, D | 1 |
| Gong, P | 1 |
| Hou, Y | 1 |
| Liu, Y | 1 |
1 other study available for carbamylhydrazine and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of 4-((6,7-dimethoxyquinoline-4-yl)oxy)aniline derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Design; fms-Like Tyros | 2019 |